EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PROCEPT BioRobotics's Enterprise Value is $3,388.7 Mil.
PROCEPT BioRobotics's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $-126.2 Mil. Therefore, PROCEPT BioRobotics's EV-to-FCF for today is -26.86.
The historical rank and industry rank for PROCEPT BioRobotics's EV-to-FCF or its related term are showing as below:
PRCT'
s EV-to-FCF Range Over the Past 10 Years
Min: -54.64 Med: -16.46 Max: -0.7
Current: -26.86
During the past 5 years, the highest EV-to-FCF of PROCEPT BioRobotics was -0.70. The lowest was -54.64. And the median was -16.46.
PRCT's EV-to-FCF is ranked worse than 100% of 361
companies
in the Medical Devices & Instruments industry
Industry Median: 28.3
vs PRCT: -26.86
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for PROCEPT BioRobotics's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PROCEPT BioRobotics's EV-to-FCF
For the Medical Devices subindustry, PROCEPT BioRobotics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PROCEPT BioRobotics's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PROCEPT BioRobotics's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where PROCEPT BioRobotics's EV-to-FCF falls into.
PROCEPT BioRobotics's current Enterprise Value is $3,388.7 Mil.
PROCEPT BioRobotics's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-126.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
PROCEPT BioRobotics's PE Ratio for today is calculated as:
PROCEPT BioRobotics's share price for today is $68.70.
PROCEPT BioRobotics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.120.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PROCEPT BioRobotics EV-to-FCF Related Terms
Thank you for viewing the detailed overview of PROCEPT BioRobotics's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
PROCEPT BioRobotics (PROCEPT BioRobotics) Business Description
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRCT has been successfully added to your 